Jonathan Tomaszewski
@dr_jonathant
Followers
2K
Following
722
Media
314
Statuses
1K
Radiation Oncologist, Ballarat Austin Radiation Oncology Centre • Views my own #radonc 🇦🇺
Victoria, Australia
Joined July 2014
Would be really helpful to be able to generate individualised estimates of MFS/PCSS/OS for salvage RT alone (beyond the subgroup data from Supp Table 4). Any plans for a nomogram/calculator, or suggestions re how to go about this? #radonc #pcsm
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data https://t.co/iQYNYwYGO3 This systematic review and meta-analysis by the DADSPORT Collaboration
0
2
6
Curious to hear from #radonc re whether they contour & limit lumbosacral plexus when boosting involved pelvic nodes in #prostatecancer? (e.g PEACE V used 65Gy/25# which is 74.75Gy EQD2 for a/b=2) 🤔 @alison_tree @PBlanchardMD @piet_ost @dr_alimuhammad @TylerSbrt
10
1
14
Expect substantial overlap with PROSPECT-eligible patients ( https://t.co/hDFChtmwgx)
#radonc
nejm.org
Pelvic radiation plus sensitizing chemotherapy with a fluoropyrimidine (chemoradiotherapy) before surgery is standard care for locally advanced rectal cancer in North America. Whether neoadjuvant c...
0
0
3
OCUM trial n=~1100 but majority not informative re RT omission. Key group n=257, stage II/III <12cm from verge treated with upfront surg (MRF>1mm, no T4 or low T3, vast majority N≤1 & 6-12cm from verge) ➡️ 5yr LR 3.8%. No info re T3 substage/EMVI https://t.co/cR7FXB8PEI
#radonc
1
6
16
Let's have a closer look 🧐at the PROSPECT trial after its presentation at #ASCO23 and publication in @NEJM
https://t.co/03yPeJodh3
#radonc #crcsm 1/n
nejm.org
Pelvic radiation plus sensitizing chemotherapy with a fluoropyrimidine (chemoradiotherapy) before surgery is standard care for locally advanced rectal cancer in North America. Whether neoadjuvant c...
4
39
99
🚨🚨🚨 PROSPECT Trial has landed! Congratulations to all investigators, @ALLIANCE_org, for this important trial! This study is important, will shape, and SHOULD alter practice for OPERATIVELY managed patients with favorable risk LA- rectal cancer. https://t.co/e8B4m9mIrS
nejm.org
Pelvic radiation plus sensitizing chemotherapy with a fluoropyrimidine (chemoradiotherapy) before surgery is standard care for locally advanced rectal cancer in North America. Whether neoadjuvant c...
4
77
153
New ESTRO ACROP GUIDELINE on Prostate Bed Delineation for Postoperative Radiotherapy in Prostate Cancer! Great work!! @a_dalpra @agomeziturriaga @AlbertoBossial
1
62
123
GETUG-AFU 22 efficacy results presented in Milan. Great discussion with chairs. To be published soon... 🇮🇹🇫🇷
1
0
1
My arguments presented this morning #EAU23 for #radiotherapy + ADT/ARPA in patients with localized high risk PSMA-N1 BRCA mutated #prostatecancer. Major thanks to all who provided input! Two parts: 1. RT/ADT/ARPA is SOC
Hey #prostatecancer tweeps, I need your help to support the use of #radiotherapy at a debate at next EAU meeting... topic: 49 yo pt with germline BRCA2 mutation cT3a PSA 45 ISUP2 N0 on CI but N1 on PSMA M0 arguments + references much appreciated...
2
22
57
Full time consultant position available - join our team in Ballarat! 🇦🇺👇 https://t.co/ud5zl18yBp
0
0
0
Would interpret with great caution. Small numbers, retrospective & conflicts with randomised data incl RAPIDO showing equivalent QoL/LARS/late GI tox ( https://t.co/SihQjTUheJ)
#radonc #rectalcancer
Read our work on bowel functional outcomes after short or long-course radiation for rectal cancers in @DCRjournal from @TataMemorial Greater incidence of any low anterior resection syndrome after SCRT, similar incontinence @DCREdInChief @TechColoproctol @ColorectalDis
1
1
3
Fantastic overview of recent & historical loc adv #rectalcancer trials & framework for TNT decision-making #radonc #gicsm @tarik_sammour
Hey Friends! Let’s discuss management of locally advanced rectal cancer! #RadOnc #GIOnc Check out the results of this poll! https://t.co/6DsMkKdCJw Let’s dive in to review! 🧵 🧵 1/
1
2
5
Respected voices in #skincancer #radonc offering their perspective and urging caution re wide field RT/VMAT for “skin field cancerisation” https://t.co/9yOGBF3Vno
0
3
6
Wonder if #dermtwitter has any thoughts to share on this thread? 👇 @MDJenniferChoi
Think RT likely to be safe in pts with albinism but will tag others for their thoughts @Sushilberiwal @CatharineWest3 @xrtGenomics @carmenbergom @HenningWillers #radonc
0
0
1
Think RT likely to be safe in pts with albinism but will tag others for their thoughts @Sushilberiwal @CatharineWest3 @xrtGenomics @carmenbergom @HenningWillers #radonc
hello #radonc and #medtwitter community! may I ask you a question please! Do you have any experience in treating patients having albinism for prostate #pcsm cancer with radiotherapy ? Do you think that there is any major risk of toxicity or second cancers?Thank you for answering!
1
0
3
A recurring discussion - such is the nature of Twitter ( https://t.co/wDC9kaLblV). Inevitably #radonc will come across as defensive, so pleasing to see perspective offered by Urologists in this thread @uroegg @chrisfilson_uro @ChapinMD
0
0
4
Breast cancer and other patients with axillary dissection (without oedema) don’t need to avoid IV’s or BP in that arm. Let’s get rid of universal arm banding. They cause unintended harm. Instead, shared decisions and personalised care. New advice here: https://t.co/DMBB5WGfkF
0
0
1
"We, therefore, conclude that higher CV risk should be managed optimally in the CV sense but this finding should not be an indication for the preferential use of LHRH an- tagonists in patients with prostate cancer." #pcsm #prostatecancer @JCO_ASCO
https://t.co/XF0kpcs5RQ
0
0
4
Enjoyed this practical overview of radiation myelopathy post spine SBRT from @weeloonong et al. https://t.co/0MLurKgCjs
#radonc #pallonc
Want to get an overview on radiation myelopathy from spine SBRT? A comprehensive review led by Dr Wee Loon Ong @AlfredHealth @Sunnybrook and @SahgalArjun the fantastic leader in spine SBRT @Sunnybrook 🇨🇦🇦🇺🇺🇸
0
1
6
New online calculator to estimate outcomes for T1-2 N1 breast cancer after mastectomy: https://t.co/Zr5eapDrFb Hope this helps individualize decision-making re: PMRT in this controversial population #bcsm
0
0
4